First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial. This is an ASCO ...
Artificial intelligence and predictive analytics are advancing diabetes prevention, diagnosis, and management by integrating data from continuous glucose monitors, electronic health records, and other ...
PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results